Theratechnologies (TH) Stock Price, News & Analysis

Company Overview

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.

Key Stats

• Today's Range: C$4.36 to C$4.53
• 50-Day Range: C$4.47 to C$4.47
• 52-Week Range: C$1.59 to C$4.73
• Volume: 35,472 shs
• Average Volume: 75,081 shs
• Market Capitalization: C$205.53 million
• P/E Ratio: N/A
• Dividend Yield: 3.76%
• Price Target: N/A
• Consensus Rating: Hold

Theratechnologies Stock Analysis - MarketRank™

Theratechnologies scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.0 / 5
• Analyst Rating: Hold

Consensus Rating

Theratechnologies has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

Theratechnologies has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Theratechnologies is -23.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Theratechnologies is -23.53, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Growth Ratio

Due to a projected decrease in earnings for Theratechnologies, their PEG ratio cannot be calculated.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for TH.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

Theratechnologies is a leading dividend payer. It pays a dividend yield of 3.76%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

Theratechnologies does not have a long track record of dividend growth.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Theratechnologies this week, compared to 0 articles on an average week.

Search Interest

Only 2 people have searched for TH on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Theratechnologies insiders have not sold or bought any company stock.

Percentage Held by Insiders

1.22% of the stock of Theratechnologies is held by insiders.

Percentage Held by Institutions

0.47% of the stock of Theratechnologies is held by institutions.

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Medical
• Industry: Biotechnology
• Sub-Industry: Restaurants, Hotels, Motels
• Current Symbol: TSE:TH
• CIK: N/A
• Web: www.theratech.com
• Phone: +1-514-3367800
• Fax: N/A
• Employees: 103
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): C($0.19)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 149.68
• P/E Growth: -8.5
• Net Income: -C$1.96 million
• Net Margins: -19.83%
• Pretax Margin: N/A
• Return on Equity: 47.31%
• Return on Assets: 5.15%

Debt

• Debt-to-Equity Ratio: -156.22
• Current Ratio: 0.84
• Quick Ratio: 0.64

Sales & Book Value

• Annual Sales: C$84.38 million
• Price / Sales: 2.44
• Cash Flow: C$1.19 per share
• Price / Cash Flow: 3.76
• Book Value: C($0.57) per share
• Price / Book: -7.90

Miscellaneous

• Outstanding Shares: 45,980,000
• Free Float: N/A
• Market Cap: C$205.53 million
• Optionable: Not Optionable
• Beta: 0.26